Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Description

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: * To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. * To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .

Conditions

Hematopoietic Cell Transplant, Solid Organ Transplant, Respiratory Viral Infection

Study Overview

Study Details

Study overview

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: * To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. * To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Condition
Hematopoietic Cell Transplant
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham's (UAB), Birmingham, Alabama, United States, 35294

Little Rock

Arkansas Children's Hospital, Little Rock, Arkansas, United States, 72202

Washington

Children's National Medical, Washington, District of Columbia, United States, 20010

Miami

University if Miami, Miami, Florida, United States, 33146

Atlanta

Emory and Children's Healthcare of Atlanta, Atlanta, Georgia, United States, 30322

Chicago

University of Chicago Medicine Comer Children's Hospital, Chicago, Illinois, United States, 60637

Boston

Boston Children's Hospital, Boston, Massachusetts, United States, 02115

Ann Arbor

C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States, 48109

Detroit

Children's Hospital of Michigan, Detroit, Michigan, United States, 48201

Minneapolis

University of Minnesota, Minneapolis, Minnesota, United States, 55455

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is not an HCT donor for a participant enrolled on the VIPER study.
  • * Not available to provide pre-transplant research blood sample.

Ages Eligible for Study

to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Arkansas Children's Hospital Research Institute,

Gabriela Maron, MD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital

William J. Steinbach, MD, PRINCIPAL_INVESTIGATOR, Arkansas Children's Hospital Research Institute

Study Record Dates

2029-08